TK-006 clinical trials
Also written TK006.
A product of Denosumab; its studies count on that page too.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How each study uses TK-006 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 1 Jun 2010 · PROLIA · BLA 125320 (FDA, Drugs@FDA; as Denosumab)
- European Union
- 26 May 2010 · Prolia · EMEA/H/C/001120 (EMA; as Denosumab)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2017 | 2 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Related medicines
As reviewed, each with the page that says it.
- A biosimilar of Denosumab
Studies
Open first, then newest update. How each study uses TK-006 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Safety Assessment of Repeated Administration of TK006 in Patients With Breast Cancer-related Bone MetastasesStatus unknownPhase 1Jiangsu T-Mab Biopharma Co.,LtdNCT03487055Written as TK006
- Assessment of Anti-RANKL Antibody in Post-menopausal WomenStatus unknownPhase 1Jiangsu T-Mab Biopharma Co.,LtdNCT03242512Written as TK006
- Assessment of TK006 in Patients With Breast Cancer-related Bone MetastasesStatus unknownPhase 1Jiangsu T-Mab Biopharma Co.,LtdNCT03239756Written as TK006